Hudson Bay Capital Management’s Genmab GMAB Stock Holding History

Hudson Bay Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.07M	Buy	330,000 +20,000	+6%	+$532K	0.02%	395
2026 Q1	$8.32M	Sell	310,000 -15,000	-5%	-$450K	0.03%	356
2025 Q4	$10M	Buy	325,000 +60,000	+23%	+$1.87M	0.03%	342
2025 Q3	$8.13M	Sell	265,000 -35,000	-12%	-$853K	0.03%	406
2025 Q2	$6.2M	Sell	300,000 -5,000	-2%	-$103K	0.02%	492
2025 Q1	$5.97M	Sell	305,000 -235,000	-44%	-$4.93M	0.02%	547
2024 Q4	$11.3M	Buy	540,000 +275,000	+104%	+$6.04M	0.04%	340
2024 Q3	$6.46M	Hold	265,000	–	–	0.03%	366
2024 Q2	$6.66M	Buy	265,000 +175,000	+194%	+$4.96M	0.03%	321
2024 Q1	$2.69M	Sell	90,000 -5,000	-5%	-$147K	0.01%	416
2023 Q4	$3.02M	Buy	95,000 +45,000	+90%	+$1.41M	0.02%	386
2023 Q3	$1.76M	Buy	50,000 +20,000	+67%	+$762K	0.01%	501
2023 Q2	$1.14M	Buy	+30,000	New	+$1.2M	0.01%	573
2022 Q4	–	Sell	-76,780	Closed	-$2.47M	–	1035
2022 Q3	$2.47M	Buy	+76,780	New	+$2.7M	0.02%	680

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Hudson Bay Capital Management's GMAB Position: Q2 2026 in Review

Hudson Bay Capital Management increased its Genmab (GMAB) stake by 6.5% in Q2 2026, buying an estimated $532K and bringing the position to 330,000 shares worth $9.07M. The position accounts for 0.02% of the portfolio, ranked #395.

Hudson Bay Capital Management first reported a position in GMAB in Q3 2022 and has held it in 14 quarters since. The position peaked at $11.3M in Q4 2024. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Hudson Bay Capital Management held 330,000 shares of Genmab worth $9.07M as of Q2 2026.
Hudson Bay Capital Management bought 20,000 Genmab shares in Q2 2026, an estimated $532K.
Genmab made up 0.02% of Hudson Bay Capital Management's portfolio in Q2 2026, its #395 holding.
Hudson Bay Capital Management first reported a position in Genmab in Q3 2022 and has held it in 14 quarters since.
Hudson Bay Capital Management's Genmab position peaked at $11.3M in Q4 2024.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.